We develop efficient, robust and scalable processes for active pharmaceutical ingredients, with an emphasis on quality, consistency and long-term sustainability.
Our approach bridges the gap between scientific research and commercial manufacturing — turning innovative chemistry into practical, reproducible and scalable processes. We optimise synthetic routes, improve process efficiency, manage impurities, enhance yields, and develop manufacturing processes designed for consistent quality and reliable scale-up.
Seven areas that shape how we take a molecule from a structure on paper to a process that runs reliably at scale.
Developing and optimising practical, efficient and scalable synthetic processes for active pharmaceutical ingredients.
Improving yield, purity, cycle time, solvent selection and overall process efficiency across every campaign.
Understanding impurity profiles and developing effective strategies to achieve consistent product quality.
Supporting the seamless transition of processes from laboratory development through to commercial manufacturing.
Robust analytical approaches that support process understanding, quality assessment and product consistency.
Exploring innovative approaches that improve process economics without compromising quality.
Building capability around specialised pharmaceutical molecules and challenging development opportunities.
Chromatography and wet chemistry run alongside process development, so a route is characterised as it is built rather than after the fact.
Route scouting, process development and scale-up under a mutual non-disclosure agreement — signed before any technical exchange.
